Treatment of Higher-Risk Patients With an Indication for Revascularization
Ajay J. Kirtane(Columbia University Irving Medical Center), Jeffrey W. Moses(Good Samaritan University Hospital), Nir Uriel(New York Proton Center), Mauricio G. Cohen(Santa Ana College), Adhir Shroff(Cardiovascular Research Foundation), Darshan Doshi(Massachusetts General Hospital), Igor F. Palacios(Massachusetts General Hospital), Dimitri Karmpaliotis(Columbia University), Gregg W. Stone(Cardiovascular Institute of the South), Nirat Beohar(Radiance Technologies (United States)), George Dangas(Mount Sinai Hospital), E. Magnus Ohman(Office of Science), Manish A. Parikh(NewYork–Presbyterian Brooklyn Methodist Hospital), Martin B. Leon(Columbia University Irving Medical Center), John M. Lasala(Lehigh Valley Hospital-Pocono), William W. O’Neill(Henry Ford Health System), William Lombardi(University of Washington), Navin K. Kapur(Tufts Medical Center)
Cited by 247
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k